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Background: Current evidence on the decline in the prevalence of female genital mutilation or 
cutting (FGM/C) has been lacking worldwide. This study analyses the prevalence estimates and 
secular trends in FGM/C over sustained periods (i.e.1990-2017). Its aim is to provide analytical 
evidence on the changing prevalence of FGM/C over time among the 0-14 years girls, and 
examine geographic variations in low-and middle-income countries (LMICs). 
Methods:  Analysis on the shift in prevalence of FGM/C was undertaken using the DHS and 
MICS datasets from Africa and Middle East. A random-effects model was used to derive overall 
prevalence estimates. Using Poison regression models, we conducted time trends analyses on the 
FGM/C prevalence estimates between 1990 and 2017. 
 
Findings: We included 90 DHS and MICS datasets for 208,195 children (0-14 years) from 29 
countries spread across Africa and two countries in Western Asia.  The prevalence of FGM/C 
among children varied greatly between countries and regions and, also within countries over 
survey periods. The percentage decline in the prevalence of FGM/C among the 0 to 14-year-old 
children was highest in East Africa, followed by North and West Africa. The prevalence 
decreased by 787% in East Africa, from 71.4% in 1995 to 8.0% in 2016. In North Africa, the 
percentage decreased from 57.7% in 1990 to 14.1 in 2015. In West Africa, the prevalence 
decreased from 73.6% in 1996 to 25.4 in 2017. The results of the trend analysis showed a 
significant shift downwards in the prevalence of FGM/C among children aged 0-14 years in such 
regions and sub-regions of East Africa, North Africa and West Africa. East Africa has 
experienced a much faster decrease in the prevalence of the practice (trend = -7.3%, 95% CI -
7.5% to -7.1%) per year from 1995 to 2014. By contrast, the decline in prevalence has been 
much slower in North Africa (trend = -4.4%, 95% CI -4.5% to -4.3%) and West Africa (trend = -
3.0%, 95 CI -3.1% to -2.9%).  
 
Interpretation:  The prevalence of FGM/C among children aged 0-14 years varied greatly 
between countries and regions and, also within countries over survey periods. There is evidence 
of huge and significant decline in the prevalence of FGM/C among children across countries and 
regions. There is a need to sustain comprehensive intervention efforts and further targeted efforts 
in countries and regions still showing high prevalence of FGM/C among children, where the 
practice is still pervasive.  
 
 
What is already known about this topic? 
• FGM/C is highly concentrated in many low-and middle-income countries particularly 
in Africa and western Asia.  
• The practice is viewed as a child abuse and a gross violation of children’s and 
women’s human rights; and is deemed unlawful by many countries and condemned by 
many organisations. 
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• It has devastating health consequences especially in terms of sexual, childbirth and 
mental health. 
What are the new findings? 
• The prevalence of FGM/C among children varied greatly between countries and 
regions and, also within countries over survey periods  
• We found evidence of significant decline in the prevalence of FGM/C in the last three 
decades among children aged 0-14 years in most of the countries and regions 
particularly in East and North and West Africa in the last three decades. We show that 
the picture looks different in Western Asia where the practice remains and affects the 
same age group.  
• Recommendations for policy 
• Evidence-based policies targeting socio-economic and cultural support for children at 
risk of FGM/C in LMICs should be pursued vigorously. 
• Appropriate research design, data collection, interventions containing religious and 
culturally sensitive elements remains important public health policy priority. 
Introduction  
 
Recent estimates show that more than 200 million women and children around the world have 
undergone the female genital mutilation and cutting (FGM/C).
1,2 
  All the available data clearly 
refers to Africa and  some Middle Eastern regions  (including Iraq and Yemen)  as areas where 
the practice is particularly most prevalent. Further findings from recent global research revealed 
the existence of such a practice in India, Indonesia, Israel, Malaysia, Thailand and the United 
Arab Emirates. Likewise, data from censuses and household and hospital records indicate that 
FGM/C constitutes a massive global health challenge in the sense that, the high burden of 
FGM/C is clearly not confined to African and Middle Eastern countries, but extends to Europe, 
North and South America, especially as a result of migration. 
2-6
 Incidents of FGM/C in the 
western world are reported particularly from among asylum seekers and immigrants who have 
moved from regions where FGM/C is practised in order to settle in developed countries. 
3-6
 
Those who live in Africa have been affected by the practice as a result of socioeconomic and 
cultural issues. . Thus, there is an emerging consensus that more than three million children in 
Africa are now at risk each year.
7 
In the present paper, we first offer an analytical picture of the 
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estimates on the prevalence of FGM/C and identify secular trends limiting the study population 
to the 0-14 young girls in LMICs.  
 
The ultimate aim of this study is to inform decision-making processes and influence policy 
responses and public health intervention across many geographic regions and countries sharing 
the same socio-economic and cultural backgrounds (such as unemployment level, the level of 
education, and religion and ethnicity) .The focus on these backgrounds is accounted for by the 
large number of selected regions in which well-tailored intervention programmes may be 
necessary to combat the practice.  
 
Accurate, up-to-date information on prevalence of FGM/C among children is necessary for the 
development of national and international health policies for prevention these practice; and 
would allow international public-health policy-makers to assign sufficient priority and resources 
to its prevention. Though there are existing systematic reviews on current prevalence estimates 
of FGM/C emanating from most international agencies
14-18
, there are no pooled analyses of 
nationally representative survey data to examine the burden of FGM/C among children. Children 
aged 0-14 years were considered in this review partly because we wanted to understand whether 
the years long campaigns on FGM/C among mothers has an impact on the reduction in the 
prevalence among their children as children are relatively too young to understand what is best 
for themselves, compared to their adult women counterparts who, on personal, cultural and 
socio-economic grounds, may engage in FGM/C.  To fill this research gap, we therefore 
systematically gathered all the survey datasets to asses (1) the contemporary prevalence 
estimates of FGM/C among children aged 0-14 years; and (2) whether significant downward 
trend in the prevalence estimates or not; and (3) whether burden of FGM/C among children vary 
across different geographical regions.  
 
Methods 
 
Study design and data 
We used data from the DHS as developed by ICF International and the MICS directed by 
UNICEF. ICF International and UNICEF provide technical assistance to countries conducting 
these national surveys. The two surveys are highly comparable and the technical teams 
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developing and supporting it are in close collaboration.  Both DHS and MICS surveys provide 
national representative data of households and estimates of adult women and children.  
 
This study examines the secular trends in the prevalence of FGM/C, focusing on countries where 
DHS/MICS data is available, and on regions which significantly contribute to the global 
prevalence in FGM/C. Evidence suggests that international response has targeted such countries 
on account of the high prevalence observed in FGM/C practice or based on the number of 
women and girls at risk. This is the case despite evidence that prevalence may be low in those 
regions. Among other things, the DHS and MICS survey datasets give details about the health 
and well-being of children as well as women in countries affected by FGM /C practices. The 
surveys used a two-stage cluster and probability sampling design, with oversampling of certain 
categories of respondents. In the first stage, "clusters" were selected from larger regional units 
within countries using sample weights techniques to obtain nationally representative estimates of 
indicators. Subsequently, the second stage of sampling, which involved the systematic sampling 
of households from the selected enumeration areas, was carried out. Data collection procedures 
and response rates for all DHS and MICs surveys were all published in each survey report. 
 
The datasets on FGM/C are available in 29 countries spread across five United Nations sub-
regions.  Based on nationally representative samples of women and children, these surveys 
produce data that make it possible to calculate both the FGM/C prevalence and secular trends at 
both the national and sub-regional levels.  In many of the targeted countries, more recent surveys 
have been produced.
8-11
 In order to provide an accurate and reliable estimate of the current 
FGM/C practices in these countries and regions, we searched the DHS and MICS databases 
(without restriction on language or date of publication) to look for FGM/C data on women and 
their daughters or children.  
 
 
Statistical analysis 
 
Meta-analysis of FGM/C prevalence estimates 
Apparent prevalence estimates were computed using the total reported number of women and 
children who have undergone FGM/C in each country. The overall prevalence of FGM/C were 
pooled and compared by proportion across countries and regions using a meta-analysis 
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technique. Before making such a move, we used the Freeman-Tukey variant of the arcsine 
square root transformed proportion suitable for pooling. This was necessary to stabilise the raw 
proportions of women and children that have undergone FGM/C from each of the included 
data.
20
 Thereafter, the DerSimonian and Laird random-effects model was used to summarize the 
data.
 21 
 
The logit effect size for the prevalence of FGM/C, its standard error, and the inverse variance 
weight are given below:  
 
ESi=Loge ………………………………….……………(1) 
SEi= + 	
…………………..………..………….……(2) 
Wi=

= np (1 —P) ………………………………………...(3) 
Where p represents the proportion (percentage) of women and children that have undergone 
FGM/C and n is the total number of women and children that have undergone the practice in the 
sample surveyed. The final pooled logit results and 95% confidence intervals (CIs) were 
transformed back into proportion for ease of interpretation using: 
 
        P=

	 …………………………………………..……..(4) 
 
To assess the variation percentage across surveys, we inspected the forest plot and used the chi-
squared test and the I
2
 statistics.
22
 the result was presented as a forest plot with 95% confidence 
intervals (CIs) expressed in percentage. Study-level influence on the estimated FGM/C 
prevalence was also evaluated using study-level characteristics such as survey year, survey 
country, survey period and the type of survey (DHS/MICS) in a univariate and multivariate 
meta-regression. We used a significance level of 0.05 for P-values in all statistical analysis. The 
bulk of data analysis was conducted using Stata version 14 for Windows (Stata Corp, College 
Station, Texas). This study was conducted and reported in line with the meta-analysis of 
Observational Studies in Epidemiology (MOOSE) guideline.
23
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Secular trend analysis 
Using Poison regression models, we conducted time trends analyses on the FGM/C prevalence 
estimates between 1990 and 2017. Regression analyses were conducted using annual data on 
prevalence with women or girls that have been mutilated as the outcome, and the Survey 
calendar year as the predictor. This method allows for estimation of time trends across individual 
calendar years to obtain the average annual percentage change (AAPC), depending on whether 
the rate of change over the previous year is constant.
24
 The Poisson regression procedure fits a 
model of the following form: 
 
Log (Cases y )  =b 0+b1y+log (sample  s ize)……………… (1) 
 
where ‘cases’ equals the number of FGM/C cases reported per year, ‘log’ is the natural log, b0 is 
the intercept, b1 is the trend, y is the year. In the equation, each year is represented by 0, 1, 
2……14 (where year 0 is 1990, year 1 is 1991, and so on until 2017). The log of ‘sample size’ 
was subsequently entered as the offset. The AAPC was calculated using the following formula: 
  
AAPC= (eb1−1) ×100……………………  ……………. (2) 
 
We also chose to meta-estimate one temporal trend from all the studies, accounting for 
correlations among multiple time intervals within studies.
25
 This indicates that the number of 
time points for which FCM/C was estimated varied across studies, and some of these included 
only one-time point. 
 
 Results 
Description of included survey datasets 
The countries, year of data collection, and the surveys characteristics are listed in Table 1. The 
surveys were conducted between 1990 and 2017. This analysis included 90 DHS and MICS 
datasets for 208,195 children (0-14 years) from 29 countries spread across Africa and two 
countries in Western Asia.  Most of the surveys were DHS (n=55), and 35 were MICS. Most of 
the surveys were from West Africa (n=54), followed by East Africa (n=17), North Africa 
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(n=10), Central Africa (n=6) and West Asia (n=3) (Figure 1). Highested numbers of surveys 
were conduced in Nigeria (n=7), Senegal (n=7) and Mali (n=6).  
Variations in prevalence of FGM/C among children by Country and geographical regions 
Prevalence of FGM/C among children and 95% CIs from individual countries with a pooled 
estimate are shown in eFigure 1 (for Central Africa), eFigure 2 (for East Africa), eFigure 3 (for 
North Africa), eFigure 4 (West Africa) and eFigure 5 (West Asia) and summarized in Table 1.  
In Central Africa Region, the FGM/C ‘annualized year average’ was highest for Chad (13.9%), 
followed by Central Africa Republic (3.0%) and Cameroon (0.7%). The FGM/C ‘annualized 
year average’ ranged from 2.0% (Kenya) to 67.0% (Eritrea) in East Africa; from 28.4% (Egypt) 
to 41.9% (Sudan) in North Africa; 0.4% (Ghana) to 72.6% (Mali) in West Africa and from 6.3% 
(Yemen) to 21.0% (Iraq) in West Asia. 
 
  Table 1.0 DHS/MICS datasets on FGM/C among children (0-14 years) across countries and 
regions 
Region Country Number 
of survey 
Survey 
period 
Sample 
size 
Annualized year 
average (%) 
Central Africa Chad 3 2004-2015 34139 13.91 (9.60 to 18.86 
Central Africa Central African Republic 2 2006-2010 24219 3.02 (0.00 to 11.20) 
Central Africa Cameroon 1 2004 2975 0.71 (0.43 to 1.04) 
East Africa Tanzania 4 1996-2016 28718 3.17 (0.78 to 7.10) 
East Africa Somalia 1 2006 3716 45.99 (44.39 to 47.59) 
East Africa Somalia north east 1 2011 5813 30.60 (29.43) to 31.79) 
East Africa Ethiopia 3 2000-2016 22885 34.12 (15.12 to 56.26) 
East Africa Kenya 4 1998-2014 18917 10.42 (2.52 to 22.79) 
East Africa Djibouti 1 2006 1923 48.52 (46.29 to 50.75) 
East Africa Somaliland 1 2011 5729 27.70 (26.55 to 28.87) 
East Africa Eritrea 2 1995-2002 6609 67.01 (58.02 to 75.41) 
North Africa Sudan 3 1990-2014 41131 41.90 (30.88 to 53.36) 
North Africa Egypt 7 1995-2015 85036 28.40 (16.41 to 42.18) 
West Africa Burkina Faso 4 1999-2010 33021 28.00 (15.16 to 43.01) 
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 Secular trend in the prevalence of FGM/C among children aged 0-14 years 
Table 2 and Figure 2 show the trends in the prevalence of FGM/C among children within 0-14 
age range who have been subjected to FGM/C. The percentage decline in the prevalence of 
FGM/C among the 0 to 14-year-old children was highest in East Africa, followed by North and 
West Africa. The prevalence decreased by 787% in East Africa. This is, from 71.4% in 1995 to 
8.0% in 2016. In North Africa, the percentage decreased from 57.7% in 1990 to 14.1 in 2015. In 
West Africa, the prevalence decreased from 73.6% in 1996 to 25.4 in 2017. This is to be 
contrasted with the picture in the Western Asia, where the percentage increased only by 1.0% in 
1997 and 15.9% in 2013. 
 
The results of the trend analysis showed a significant shift downwards in the prevalence of 
FGM/C among children aged 0-14 years in such regions and sub-regions of East Africa, North 
Africa and West Africa. East Africa has experienced a much faster decrease in the prevalence of 
the practice (trend = -7.3%, 95% CI -7.5% to -7.1%) per year from 1995 to 2014. By contrast, 
the decline in prevalence has been much slower in North Africa (trend = -4.4%, 95% CI -4.5% 
West Africa Guinea 4 1999-2016 26576 50.35 (44.75 to 55.95) 
West Africa Ghana 1 2011 8276 0.40 (0.27 to 0.55) 
West Africa Benin 4 2001-2014 34399 1.80 (0.25 to 4.68) 
West Africa Senegal 7 2005-2016 37087 12.96 (8.63 to 18.03) 
West Africa Niger 2 1998-2006 7521 5.67 (0.00 to 25.15) 
West Africa Guinea-Bissau 3 2006-2016 23414 34.29 (28.63 to 40.19) 
West Africa Mauritania 4 2001-2015 34100 61.20 (53.61 to 68.53) 
West Africa Sierra Leone 3 2006-2010 24268 24.67 (8.87 to 45.18) 
West Africa Mali 6 1996-2015 67404 72.59 (69.98 to 75.13) 
West Africa Togo 3 2006-2014 16777 0.53 (0.21 to 0.97) 
West Africa Cote d' Ivoire 4 1999-2016 19837 13.61 (9.25 to 18.65) 
West Africa Gambia 2 2006-2010 21972 53.43 (32.14 to 74.08) 
West Africa Nigeria 7 1999-2017 104030 18.83 (14.66 to 23.39) 
Western Asia Yemen 2 1997-2013 16037 6.31 (0.00 to 28.23) 
Western Asia Iraq 1 2011 8759 21.00 (20.15 to 21.85) 
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to -4.3%) and West Africa (trend = -3.0%, 95 CI -3.1% to -2.9%). However, in Western Asia, 
between 1997 and 2015, the prevalence of FGM/C among children aged 0-14 increased by 
+19.2% (95% CI +16.9% in +21.7) per year. A non-statistically significant uptrend was also 
observed in Central Africa (trend = +0.2%, 95% CI -0.7% to +1.0). 
 
 Table 2: Regional trends in percentage of girls aged 0-14 circumcised 
Region Number of 
surveys 
Period Percentage 
relative changes 
(%) 
Average annual 
percentage changes: 
AAPC (95% CI) 
  Start  End   
Central Africa 4 2004 2015 -8.1% +0.2 (-0.7 to +1.0) 
East Africa 13 1995 2014 -787.0% -7.3 (-7.5 to -7.1) 
North Africa 9 1990 2015 -309.2% -4.4 (-4.5 to -4.3) 
West Africa 17 1996 2017 -190.3% -3.0 (-3.1 to -2.9) 
Western Asia 3 1997 2013 +94.0% +13.7 (+12.3 to +15.0) 
 
 
 
 
 
Discussion 
Main Findings 
We found that prevalence of FGM/C among children varied greatly between countries and 
regions and, also within countries over survey periods. Specifically, West, East, and North 
African countries including Mali, Mauritania, Gambia, Guinea, Djibouti and Sudan have pooled 
prevalence estimates well over 40%. These rates may be consistent with the influence of 
different predictors including geographical mobility, socioeconomic and cultural factors acting 
at individual, family and tertiary levels.  Our study found a huge and significant decline in the 
prevalence of FGM/C among children aged 0-14 years across countries and regions. This current 
evidence points towards the success of the national and international investment and policy 
Page 10 of 60
https://mc.manuscriptcentral.com/bmjgh
BMJ Global Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
11 
 
11 
 
intervention in the last three decades. One possible explanation in the decrease of FGM/C among 
young girls (0-14 years) may be due to the legal ban on FGM/C among children currently in 
place in most of these countries with strong cultural and traditional influence may have acted as 
an effective deterrent as seen in the decline among these cohorts.  
 
Although there is clear evidence of significant decline in the prevalence among the population 
studied here (0-14 year-old children), the FGM/C risk factors still prevails and potentially 
heightening the possibility of reverse trend in some countries. These risk factors include lack of, 
or poor education, poverty and continued perception of FGM/C as a potential marriage market 
activity.
 29,43
  The health and socioeconomic consequences  of FGM/C coupled with its risk 
factors may mean  growing underinvestment and Gross Domestic Product (GDP) losses, which 
itself  reflects increased loss in productivity and reduced labour efficiency in LMICs. Moreover, 
those regions and sub-regions showing high prevalence of FGM/C should be the focus on 
renewed government and donors’ policy efforts. If the goal of public policy is to ensure that the 
practice is completely eliminated, further efforts and interventions as well as service planning 
are urgently needed.  This is package of comprehensive intervention could include legislation, 
advocacy, education and multimedia communication; in order to come up with  more 
culturally-sensitive and community-engaging strategies such as forging partnership with 
religious and community leaders, youths and health workers to drive the practice 
downward.
16,18,35-41
   
 
Strengths and limitations 
There are a number of caveats to be considered when interpreting these results. The main 
limitation of the study is risk of reporting bias as similar studies of this kind. It is possible that 
responses to culturally sensitive issues such as FGM/C will have distorted the findings; it may be 
under-reported. In fact, a recent body of evidence suggests that under-reporting of FGM/C cases 
could occur
44-46
. Such an underreporting may be due to fear that new legislation banning the 
practice across many jurisdiction would lead to prosecution of relatives if disclosure was made 
about their FGM/C status. Another limitation is that we did not consider study-level participants' 
characteristics, which may have further increased the knowledge of the dynamics of FGM/C 
practices.   
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Despite these limitations, the study strengths are significant. It is a large, population-based study 
with national coverage. In addition, data of the DHS are widely perceived to be of high quality, 
as they were based on sound sampling methodology with high response rate. DHS also adhere to 
stringent ethical rules in the collection of sensitive topic such as FGM/C. Another important 
strength of this study is the number of included countries and geographic and socioeconomic 
diversities constitute a good yardstick for the region, and help to strengthen the findings from the 
study. 
 
Conclusion 
The prevalence of FGM/C among children aged 0-14 years varied greatly between countries and 
regions and, also within countries over survey periods. There is evidence of huge and significant 
decline in the prevalence of FGM/C among children across countries and regions. There is a 
need to sustain comprehensive intervention efforts. In addition, further targeted culturally 
sensitive policy intervention and other effective strategies for preventing FGM/C should be a 
major public health priority in in countries and regions still showing high prevalence of FGM/C 
among children, where the practice is still pervasive.  
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Figure legends 
Figure 1: Location of included studies 
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Figure 2: Secular trends in prevalence FGM/C among children  
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Online Only Figures 
eFigure 1: Forest of prevalence of FGM/C among children, Central Africa 
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eFigure 2: Forest of prevalence of FGM/C among children, East Africa 
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eFigure 3: Forest of prevalence of FGM/C among children, North Africa 
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eFigure 4: Forest of prevalence of FGM/C among children, West Africa 
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eFigure 5: Forest of prevalence of FGM/C among children, West Asia 
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